Skip to main content

Publisher: Elsevier

Volume 13, Number 6, 24 March 2003

Editorial Board
pp. CO2-CO2(1)

Favourites:
ADD

Contents List
pp. iii-vi(4)

Favourites:
ADD
Favourites:
ADD

Graphical Abstracts
pp. 979-991(13)

Favourites:
ADD

Inhibition of bacterial IF2 binding to fMet-tRNA(fMet) by aminoglycosides
pp. 993-996(4)
Authors: Evans, J.M.; Turner, B.A.; Bowen, S.; Ho, A.M.; Sarver, R.W.; Benson, E.; Parker, C.N.

Favourites:
ADD

Synthesis of aza and oxaglutamyl-p-nitroanilide derivatives and Their kinetic studies with -Glutamyltranspeptidase
pp. 997-1000(4)
Authors: Lherbet, C.; Morin, M.; Castonguay, R.; Keillor, J.W.

Favourites:
ADD

Syntheses and biological properties of cysteine-Reactive epibatidine derivatives
pp. 1001-1004(4)
Authors: Che, C.; Petit, G.; Kotzyba-Hibert, F.; Bertrand, S.; Bertrand, D.; Grutter, T.; Goeldner, M.

Favourites:
ADD

Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides
pp. 1005-1009(5)
Authors: Vullo, D.; Franchi, M.; Gallori, E.; Pastorek, J.; Scozzafava, A.; Pastorekova, S.; Supuran, C.T.

Favourites:
ADD

Prodrugs to enhance central nervous system effects of the TRH-like peptide pGlu-Glu-Pro-NH2
pp. 1011-1014(4)
Authors: Prokai-Tatrai, K.; Nguyen, V.; Zharikova, A.D.; Braddy, A.C.; Stevens, S.M.; Prokai, L.

Favourites:
ADD

N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship
pp. 1015-1018(4)
Authors: Burdick, D.J.; Paris, K.; Weese, K.; Stanley, M.; Beresini, M.; Clark, K.; McDowell, R.S.; Marsters, J.C.; Gadek, T.R.

Favourites:
ADD

Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors
pp. 1023-1028(6)
Authors: Quan, M.L.; Ellis, C.D.; He, M.Y.; Liauw, A.Y.; Lam, P.Y.S.; Rossi, K.A.; Knabb, R.M.; Luettgen, J.M.; Wright, M.R.; Wong, P.C.; Wexler, R.R.

Favourites:
ADD

Synthesis and binding affinity of neuropeptide Y at opiate receptors
pp. 1029-1031(3)
Authors: Kiddle, J.J.; McCreery, H.J.; Soles, S.

Favourites:
ADD

Synthesis and hybridization property of novel 2',5'-isoDNA mimic chiral peptide nucleic acids
pp. 1041-1043(3)
Authors: Abdel-Aziz, M.; Yamasaki, T.; Otsuka, M.

Favourites:
ADD

Anastatins A and B, new skeletal flavonoids with hepatoprotective activities from the desert plant Anastatica hierochuntica
pp. 1045-1049(5)
Authors: Yoshikawa, M.; Xu, F.; Morikawa, T.; Ninomiya, K.; Matsuda, H.

Favourites:
ADD

Substituted 4-methylquinolines as a new class of anti-tuberculosis agents
pp. 1051-1054(4)
Authors: Jain, R.; Vaitilingam, B.; Nayyar, A.; Palde, P.B.

Favourites:
ADD

Identification of a novel series of selective 5-HT7 receptor antagonists
pp. 1055-1058(4)
Authors: Forbes, I.T.; Cooper, D.G.; Dodds, E.K.; Douglas, S.E.; Gribble, A.D.; Ife, R.J.; Lightfoot, A.P.; Meeson, M.; Campbell, L.P.; Coleman, T.; Riley, G.J.; Thomas, D.R.

Favourites:
ADD

Alkylation of manganese(II) tetraphenylporphyrin by antimalarial fluorinated artemisinin derivatives
pp. 1059-1062(4)
Authors: Rodriguez, M.; Bonnet-Delpon, D.; Begue, J.; Robert, A.; Meunier, B.

Favourites:
ADD

α-Selective glycosylation with 5-thioglucopyranosyl donors; synthesis of an IsoMaltotetraoside mimic composed of 5-thioglucopyranose units
pp. 1063-1066(4)
Authors: Matsuda, H.; Ohara, K.; Morii, Y.; Hashimoto, M.; Miyairi, K.; Okuno, T.

Favourites:
ADD

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2
pp. 1067-1070(4)
Authors: Blackie, J.A.; Bloomer, J.C.; Brown, M.J.B.; Cheng, H.; Hammond, B.; Hickey, D.M.B.; Ife, R.J.; Leach, C.A.; Lewis, V.A.; Macphee, C.H.; Milliner, K.J.; Moores, K.E.; Pinto, I.L.; Smith, S.A.; Stansfield, I.G.; Stanway, S.J.; Taylor, M.A.; Theobald, C.J.

Favourites:
ADD

Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureas
pp. 1071-1074(4)
Authors: Urbahns, K.; Harter, M.; Vaupel, A.; Albers, M.; Schmidt, D.; Bruggemeier, U.; Stelte-Ludwig, B.; Gerdes, C.; Tsujishita, H.

Favourites:
ADD

Synthesis and biological evaluation of 4-Deacetoxy-1,7-dideoxy azetidine paclitaxel analogues
pp. 1075-1077(3)
Authors: Cheng, Q.; Kiyota, H.; Yamaguchi, M.; Horiguchi, T.; Oritani, T.

Favourites:
ADD

Regioselective hydrolysis of pentaacetyl catechin and epicatechin by porcine liver esterase
pp. 1083-1085(3)
Authors: Basak, A.; Mandal, S.; Bandyopadhyay, S.

Favourites:
ADD

N-Alkoxysulfamide, N-hydroxysulfamide, and sulfamate analogues of methionyl and isoleucyl adenylates as inhibitors of methionyl-tRNA and isoleucyl-tRNA synthetases
pp. 1087-1092(6)
Authors: Lee, J.; Kim, S.E.; Lee, J.Y.; Kim, S.Y.; Kang, S.U.; Seo, S.H.; Chun, M.W.; Kang, T.; Choi, S.Y.; Kim, H.O.

Favourites:
ADD

Discovery of 4'-[(Imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/Angiotensin II receptor antagonists
pp. 1093-1096(4)
Authors: Tellew, J.E.; Baska, R.A.F.; Beyer, S.M.; Carlson, K.E.; Cornelius, L.A.; Fadnis, L.; Gu, Z.; Kunst, B.L.; Kowala, M.C.; Monshizadegan, H.; Murugesan, N.; Ryan, C.S.; Valentine, M.T.; Yang, Y.; Macor, J.E.

Favourites:
ADD

Novel α-amino-Acid phenolic ester derivatives with intravenous anaesthetic activity
pp. 1107-1110(4)
Authors: Cooke, A.; Anderson, A.; Bennett, J.; Buchanan, K.; Gemmell, D.; Hamilton, N.; Maidment, M.; McPhail, P.; Stevenson, D.; Sundaram, H.

Favourites:
ADD

Glycine α-Ketoamides as HCV NS3 Protease Inhibitors
pp. 1111-1114(4)
Authors: Han, W.; Hu, Z.; Jiang, X.; Wasserman, Z.R.; Decicco, C.P.

Favourites:
ADD

Structure-Based de novo design of non-nucleoside adenosine deaminase inhibitors
pp. 1115-1118(4)
Authors: Terasaka, T.; Nakanishi, I.; Nakamura, K.; Eikyu, Y.; Kinoshita, T.; Nishio, N.; Sato, A.; Kuno, M.; Seki, N.; Sakane, K.

Favourites:
ADD

Conformationally-Restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-Chlorophenylbiguanide (mCPBG) and meta-Chlorophenylguanidine (mCPG)
pp. 1119-1123(5)
Authors: Rahman, A.A.; Daoud, M.K.; Dukat, M.; Herrick-Davis, K.; Purohit, A.; Teitler, M.; do Amaral, A.T.; Malvezzi, A.; Glennon, R.A.

Favourites:
ADD

Preparation of potential inhibitors of the mur-Pathway enzymes on solid support using an acetal linker
pp. 1125-1128(4)
Authors: Maletic, M.; Antonic, J.; Leeman, A.; Santorelli, G.; Waddell, S.

Favourites:
ADD

Discovery of a potent and selective agonist of the prostaglandin EP4 receptor
pp. 1129-1132(4)
Authors: Billot, X.; Chateauneuf, A.; Chauret, N.; Denis, D.; Greig, G.; Mathieu, M.; Metters, K.M.; Slipetz, D.M.; Young, R.N.

Favourites:
ADD

1H-Pyrazolo[3,4-b]pyridine Inhibitors of Cyclin-Dependent Kinases
pp. 1133-1136(4)
Authors: Misra, R.N.; Rawlins, D.B.; Xiao, H.; Shan, W.; Bursuker, I.; Kellar, K.A.; Mulheron, J.G.; Sack, J.S.; Tokarski, J.S.; Kimball, S.D.; Webster, K.R.

Favourites:
ADD

Synthesis of Imidazopyridines and Purines as Potent Inhibitors of Leukotriene A4 Hydrolase
pp. 1137-1139(3)
Authors: Penning, T.D.; Chandrakumar, N.S.; Desai, B.N.; Djuric, S.W.; Gasiecki, A.F.; Malecha, J.W.; Miyashiro, J.M.; Russell, M.A.; Askonas, L.J.; Gierse, J.K.; Harding, E.I.; Highkin, M.K.; Kachur, J.F.; Kim, S.H.; Villani-Price, D.; Pyla, E.Y.; Ghoreishi-Haack, N.S.; Smith, W.G.

Favourites:
ADD

Synthesis and Biological activity of kappa opioid receptor agonists. Part 2: Preparation of 3-aryl-2-pyridone analogues generated by solution- and solid-phase parallel synthesis methods
pp. 1141-1145(5)
Authors: Semple, G.; Andersson, B.; Chhajlani, V.; Georgsson, J.; Johansson, M.J.; Rosenquist, A.; Swanson, L.

Favourites:
ADD

Bacterial siderophores: synthesis and biological activities of novel pyochelin analogues
pp. 1147-1150(4)
Authors: Zamri, A.; Schalk, I.J.; Pattus, F.; Abdallah, M.A.

Favourites:
ADD

Novel ether derivatives of mannopeptimycin glycopeptide antibiotic
pp. 1151-1155(5)
Authors: Sum P.-E.; How, D.; Torres, N.; Petersen, P.J.; Lenoy, E.B.; Weiss, W.J.; Mansour, T.S.

Favourites:
ADD

Design and Synthesis of Potent, Non-peptide Inhibitors of HCV NS3 Protease
pp. 1157-1160(4)
Authors: Zhang, X.; Schmitt, A.C.; Jiang, W.; Wasserman, Z.; Decicco, C.P.

Favourites:
ADD

Benzamide derivatives as blockers of Kv1.3 ion channel
pp. 1161-1164(4)
Authors: Miao, S.; Bao, J.; Garcia, M.L.; Goulet, J.L.; Hong, X.J.; Kaczorowski, G.J.; Kayser, F.; Koo, G.C.; Kotliar, A.; Schmalhofer, W.A.; Shah, K.; Sinclair, P.J.; Slaughter, R.S.; Springer, M.S.; Staruch, M.J.; Tsou, N.N.; Wong, F.; Parsons, W.H.; Rupprecht, K.M.

Favourites:
ADD

Novel 5-cyclopropyl-1,4-benzodiazepin-2-ones as potent and selective IKs-blocking class III antiarrhythmic agents
pp. 1165-1168(4)
Authors: Butcher, J.W.; Liverton, N.J.; Claremon, D.A.; Freidinger, R.M.; Jurkiewicz, N.K.; Lynch, J.J.; Salata, J.J.; Wang, J.; Dieckhaus, C.M.; Slaughter, D.E.; Vyas, K.

Favourites:
ADD

A new and improved method for deglycosidation of glycopeptide antibiotics exemplified with vancomycin, ristocetin, and ramoplanin
pp. 1169-1173(5)
Authors: Wanner, J.; Tang, D.; McComas, C.C.; Crowley, B.M.; Jiang, W.; Moss, J.; Boger, D.L.

Favourites:
ADD

Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization
pp. 1175-1177(3)
Authors: Zhao, L.; O'Reilly, M.K.; Shultz, M.D.; Chmielewski, J.

Favourites:
ADD

Synthesis and properties of 11-(3,5-Di-tert-butyl-2-hydroxyphenylcarbamoyl)undecanoic acid, a new amphiphilic antioxidant
pp. 1179-1182(4)
Authors: Lodyato, V.I.; Yurkova, I.L.; Sorokin, V.L.; Shadyro, O.I.; Dolgopalets, V.I.; Kisel, M.A.

Favourites:
ADD

2-(Anilinomethyl)imidazolines as α1 adrenergic receptor agonists: α1a subtype selective 2'-heteroaryl compounds
pp. 1183-1186(4)
Authors: Speake, J.D.; Navas, F.; Bishop, M.J.; Garrison, D.T.; Bigham, E.C.; Hodson, S.J.; Saussy, D.L.; Liacos, J.A.; Irving, P.E.; Sherman, B.W.

Favourites:
ADD

Structure-activity relationships studies of the anti-angiogenic activities of linomide
pp. 1187-1189(3)
Authors: Shi, J.; Xiao, Z.; Ihnat, M.A.; Kamat, C.; Pandit, B.; Hu, Z.; Li P.-K.

Favourites:
ADD

N-Phenyl-N-purin-6-yl ureas: The design and synthesis of p38α MAP kinase inhibitors
pp. 1191-1194(4)
Authors: Wan, Z.; Boehm, J.C.; Bower, M.J.; Kassis, S.; Lee, J.C.; Zhao, B.; Adams, J.L.

Favourites:
ADD

3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility
pp. 1195-1198(4)
Authors: Black, W.C.; Brideau, C.; Chan, C.; Charleson, S.; Cromlish, W.; Gordon, R.; Grimm, E.L.; Hughes, G.; Leger, S.; Li, C.; Riendeau, D.; Therien, M.; Wang, Z.; Xu, L.; Prasit, P.

Favourites:
ADD

Indanyl piperazines as melatonergic MT2 selective agents
pp. 1199-1202(4)
Authors: Mattson, R.J.; Catt, J.D.; Keavy, D.; Sloan, C.P.; Epperson, J.; Gao, Q.; Hodges, D.B.; Iben, L.; Mahle, C.D.; Ryan, E.; Yocca, F.D.

Favourites:
ADD

Inhibitors of A production: solid-phase synthesis and SAR of α-hydroxycarbonyl derivatives
pp. 1203-1206(4)
Authors: Wallace, O.B.; Smith, D.W.; Deshpande, M.S.; Polson, C.; Felsenstein, K.M.

Favourites:
ADD

Structure-activity relationships of some opiate glycosides
pp. 1207-1214(8)
Authors: Stachulski, A.V.; Scheinmann, F.; Ferguson, J.R.; Law, J.L.; Lumbard, K.W.; Hopkins, P.; Patel, N.; Clarke, S.; Gloyne, A.; Joel, S.P.

Favourites:
ADD

Azido-Containing aryl -Diketo acid HIV-1 integrase inhibitors
pp. 1215-1219(5)
Authors: Zhang, X.; Pais, G.C.G.; Svarovskaia, E.S.; Marchand, C.; Johnson, A.A.; Karki, R.G.; Nicklaus, M.C.; Pathak, V.K.; Pommier, Y.; Burke, T.R.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more